SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007355
Filing Date
2022-05-05
Accepted
2022-05-05 16:05:43
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20220331x10q.htm   iXBRL 10-Q 1244653
2 EX-31.1 idra-20220331xex31d1.htm EX-31.1 13879
3 EX-31.2 idra-20220331xex31d2.htm EX-31.2 13589
4 EX-32.1 idra-20220331xex32d1.htm EX-32.1 7138
5 EX-32.2 idra-20220331xex32d2.htm EX-32.2 7747
6 GRAPHIC idra-20220331x10q004.jpg GRAPHIC 6453
  Complete submission text file 0001558370-22-007355.txt   5792009

Data Files

Seq Description Document Type Size
7 EX-101.SCH idra-20220331.xsd EX-101.SCH 45587
8 EX-101.CAL idra-20220331_cal.xml EX-101.CAL 35566
9 EX-101.DEF idra-20220331_def.xml EX-101.DEF 176098
10 EX-101.LAB idra-20220331_lab.xml EX-101.LAB 351595
11 EX-101.PRE idra-20220331_pre.xml EX-101.PRE 301138
58 EXTRACTED XBRL INSTANCE DOCUMENT idra-20220331x10q_htm.xml XML 1022224
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 22896148
SIC: 2836 Biological Products, (No Diagnostic Substances)